Literature DB >> 25065888

Tools and techniques to study ligand-receptor interactions and receptor activation by TNF superfamily members.

Pascal Schneider1, Laure Willen2, Cristian R Smulski1.   

Abstract

Ligands and receptors of the TNF superfamily are therapeutically relevant targets in a wide range of human diseases. This chapter describes assays based on ELISA, immunoprecipitation, FACS, and reporter cell lines to monitor interactions of tagged receptors and ligands in both soluble and membrane-bound forms using unified detection techniques. A reporter cell assay that is sensitive to ligand oligomerization can identify ligands with high probability of being active on endogenous receptors. Several assays are also suitable to measure the activity of agonist or antagonist antibodies, or to detect interactions with proteoglycans. Finally, self-interaction of membrane-bound receptors can be evidenced using a FRET-based assay. This panel of methods provides a large degree of flexibility to address questions related to the specificity, activation, or inhibition of TNF-TNF receptor interactions in independent assay systems, but does not substitute for further tests in physiologically relevant conditions.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Avidity; Cell death; Interaction; Ligand; Receptor

Mesh:

Substances:

Year:  2014        PMID: 25065888     DOI: 10.1016/B978-0-12-801430-1.00005-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  14 in total

1.  Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells.

Authors:  Maria-Luisa del Rio; Carlos Fernandez-Renedo; Olivier Chaloin; Stefanie Scheu; Klaus Pfeffer; Yasushi Shintani; Jose-Antonio Perez-Simon; Pascal Schneider; Jose-Ignacio Rodriguez-Barbosa
Journal:  MAbs       Date:  2016-01-11       Impact factor: 5.857

2.  An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions.

Authors:  Mohameedyaseen Syedbasha; Janina Linnik; Deanna Santer; Daire O'Shea; Khaled Barakat; Michael Joyce; Nina Khanna; D Lorne Tyrrell; Michael Houghton; Adrian Egli
Journal:  J Vis Exp       Date:  2016-03-14       Impact factor: 1.355

3.  Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Authors:  Sonia Schuepbach-Mallepell; Dolon Das; Laure Willen; Michele Vigolo; Aubry Tardivel; Luc Lebon; Christine Kowalczyk-Quintas; Josquin Nys; Cristian Smulski; Timothy S Zheng; Klaus Maskos; Alfred Lammens; Xuliang Jiang; Henry Hess; Seng-Lai Tan; Pascal Schneider
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

4.  Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia.

Authors:  Christine Kowalczyk-Quintas; Sonia Schuepbach-Mallepell; Michele Vigolo; Laure Willen; Aubry Tardivel; Cristian R Smulski; Timothy S Zheng; Jennifer Gommerman; Henry Hess; Jacques-Eric Gottenberg; Fabienne Mackay; Olivier Donzé; Pascal Schneider
Journal:  J Biol Chem       Date:  2016-07-22       Impact factor: 5.157

5.  A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.

Authors:  Philipp Haselmayer; Michele Vigolo; Josquin Nys; Pascal Schneider; Henry Hess
Journal:  Eur J Immunol       Date:  2017-04-24       Impact factor: 5.532

6.  Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling.

Authors:  Cristian R Smulski; Marion Decossas; Neila Chekkat; Julien Beyrath; Laure Willen; Gilles Guichard; Raquel Lorenzetti; Marta Rizzi; Hermann Eibel; Pascal Schneider; Sylvie Fournel
Journal:  Cell Death Dis       Date:  2017-02-09       Impact factor: 8.469

7.  A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.

Authors:  Michele Vigolo; Melissa G Chambers; Laure Willen; Dehlia Chevalley; Klaus Maskos; Alfred Lammens; Aubry Tardivel; Dolon Das; Christine Kowalczyk-Quintas; Sonia Schuepbach-Mallepell; Cristian R Smulski; Mahya Eslami; Antonius Rolink; Edith Hummler; Eileen Samy; Yves Fomekong Nanfack; Fabienne Mackay; Maofu Liao; Henry Hess; Xuliang Jiang; Pascal Schneider
Journal:  Nat Commun       Date:  2018-03-23       Impact factor: 14.919

8.  Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab.

Authors:  Christine Kowalczyk-Quintas; Dehlia Chevalley; Laure Willen; Camilla Jandus; Michele Vigolo; Pascal Schneider
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

9.  A simple and rapid pipeline for identification of receptor-binding sites on the surface proteins of pathogens.

Authors:  Patrícia Mertinková; Amod Kulkarni; Evelína Káňová; Katarína Bhide; Zuzana Tkáčová; Mangesh Bhide
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

10.  Assessing the Functional Relevance of Variants in the IKAROS Family Zinc Finger Protein 1 (IKZF1) in a Cohort of Patients With Primary Immunodeficiency.

Authors:  Zoya Eskandarian; Manfred Fliegauf; Alla Bulashevska; Michele Proietti; Rosie Hague; Cristian Roberto Smulski; Desirée Schubert; Klaus Warnatz; Bodo Grimbacher
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.